EUVIMEDEUVIMED entdecken
Fallbericht

First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa

Ava J Dorazio, Samuel L Aitken iD, Virginia M Pierce iD, Ellen G Kline iD, Kevin M Squires iD, Jason M Pogue, Ryan K Shields iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf638 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Ava J Dorazio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Cefepime, Pseudomonas aeruginosa, Azabicyclo Compounds, Cephalosporins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe the first case of cefepime-zidebactam treatment-emergent resistance associated with clinical failure in a patient with Pseudomonas aeruginosa pneumonia. During treatment, cefepime-zidebactam minimum inhibitory concentrations increased from 8/8 to 32/32 mg/L. Whole-genome sequence analysis showed new mutations in the MexAB-OprM efflux operon that were associated with cross-resistance to ceftazidime-avibactam and imipenem-relebactam.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefepimePseudomonas aeruginosaAzabicyclo CompoundsCephalosporinsAnti-Bacterial AgentsPseudomonas InfectionsCyclooctanesDrug Resistance, Multiple, BacterialDrug Resistance, BacterialHumansMicrobial Sensitivity TestsDrug CombinationsWhole Genome SequencingMembrane Transport ProteinsMaleBacterial Outer Membrane ProteinsCeftazidimeMutationPiperidines

Stichwörter der Autor:innen

PseudomonasMexAB-OprMcefepime-zidebactamresistance

Substanzen

CefepimeAzabicyclo CompoundsCephalosporinsAnti-Bacterial Agentscefepime-zidebactamDrug CombinationsCyclooctanesMembrane Transport ProteinsBacterial Outer Membrane ProteinsCeftazidime

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
  • Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA.

ORCID-Profile: Samuel L Aitken, Virginia M Pierce, Ellen G Kline, Kevin M Squires, Ryan K Shields

Zitieren

APA

Dorazio, A. J., Aitken, S. L., Pierce, V. M., Kline, E. G., Squires, K. M., Pogue, J. M., & Shields, R. K. (2026). First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf638

Vancouver

Dorazio AJ, Aitken SL, Pierce VM, Kline EG, Squires KM, Pogue JM, et al. First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf638

BibTeX
@article{Dorazio2026,
  author = {Dorazio, Ava J and Aitken, Samuel L and Pierce, Virginia M and Kline, Ellen G and Squires, Kevin M and Pogue, Jason M and Shields, Ryan K},
  title = {First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf638}
}
Kostenlos starten →